Yesterday，Beijing Yushengtang announced，It is planned to acquire 70%rights and interests of the Japanese Pharmaceutical Industry Co., Ltd.，The cost is expected to be 700 million yen (about RMB 58.823 million)，The two parties have signed a memorandum of understanding。
    Foreign -funded mergers and acquisitions of domestic pharmaceutical stake sports betting appcompanies stake online sports bettingare commonplace，M & A domestic pharmaceutical companies are rare to acquire foreign companies。The pharmaceutical market structure is quietly having a fission。
 My stake betting app    Beijing Yushengtang (1141.HK) issued an announcement name，and Japanese Pharmaceutical Industry Co., Ltd.，Signing a memorandum of understanding for the acquisition of 70%of its equity，The main terms of the memorandum of understanding are Beijing Yushengtang intending to acquire 70%share capital rights and interests of the Japanese pharmaceutical industry，and the contracting parties intend to sign the actual agreement on July 15 or before，It is expected to involve the total cost 700 million yen。
    According to the memorandum of understanding，Beijing Yushengtang can conduct due diligence on the Japanese pharmaceutical industry's business within 60 days after signing the memorandum of understanding。Notice，Japanese pharmaceutical industry has more than 60 years of experience in producing Chinese pharmaceuticals in Japan，Production of more than 150 drugs、Herbal drugs and health products，and distribute the pharmacies and pharmacies in Japan。
    Yesterday, Hong Kong Stake Sports Bettingstocks stake online sports bettingwere weak and dragged down the downward stock price of Beijing Yushengtang，Film 0.87 Hong Kong dollars，Fall 5.44%。On the same day，Beijing Yushengtang first promoted the new Chinese medicine variety "Golden Flower Clear"，Executive Director Bai Jianjiang said，The gross profit margin of the new drug exceeds 50%，Price still has room for rise，He is confident that the new drug will contribute more than 50%to the company's income this year。
    Before the acquisition，Beijing Yushengtang has completed a number of acquisitions，And has successfully developed the shelling in Hong Kong。
    Medical Market M & A Tide
    This year's pharmaceutical market mergers and acquisitions waves are one after another，China Resources Department、National Medicine Department，Fosun、Dongsheng Department, etc., are getting more and more exposed to the group's capital strength。
    September 18, 2007 Chongqing Huiyuan Pharmaceuticals at the price of 2 million Singapore，Acquisition Singapore Second Darge Chain Pharmaceutical Enterprise Singapore New Chinese Medicine Health Products Co., Ltd. 51%shares。Chinese pharmaceutical companies have successfully taken stake online sports bettingout Stake Sports Bettingan important step in overseas mergers and acquisitions。
    March 2008，中国最大的监护仪厂商深圳迈瑞公布了其海外上市后的第一项收购协议------以2.02亿美元收购美国DataSCope公司的生命信息监护业务，After the acquisition is completed, Mai Rui will become the third largest manufacturer of the global monitoring instrument industry。
    April of that year，Wanquan Technology Pharmaceutical, which was listed in Hong Kong, officially issued an announcement.，Cash cash acquisition of COMMONWEALTH, Commonwealth, a listed company in the United States is acquired with cash of US $ 3.1175 million (approximately HK $ 24.3165 million). Biotechnolo-GIES Inc. (CBI) 39%of the issued share capital，Become the group's largest shareholder。
     Current，There are nearly 5,000 pharmaceutical manufacturing companies in China，Most of the annual sales of less than 100 million yuan; more than 7,000 pharmaceutical commercial enterprises，Most of them are small companies; more than 1,000 pharmaceutical retail chain companies，But the sales scale is small，The number of stores is not large。Analysis stake sports betting appof stake sports betting appindustry insiders，In small、San、In the background of weak，mergers and acquisitions and integration have become an important way for Chinese pharmaceutical companies to improve their competitiveness。